Member Info for hahahehehoho

Don't think you can compare this to DVRG. dvrg will signing most of their revenue profit to Aptamer group and Avacta. The breathalyser idea is over engineered , their waste water monitoring will be fine though.

What if it lands on green?

We all knew the risks, this is next generation covid testing which is either going to be a miss or total hit. It's either -50% or + 400% tomorrow anyway. Most I can see are selling out and derisking which perfectly normal the day before.

Yes, but for example, in a few months time when a hospital has a dying patient on the bed with over 50 covid drugs to choose from how will this Oxford test be able to tell doctors the current state of infection and how effective these drugs work real time ? Just inject all of them huh?
Paraytec 2 stage test could possibly cover all aspects of poc and hospital testing (except antibody)

#paraytec

Some people should always set price targets whether it be buy or sell. I always say the stock market is like the game "musical chairs" , and always stick to that thought of notion when investing or trading

Some people panic like jodrell and some people are opportunists like myself in getting the best possible deal .

That's life

Some people set pric

What about this test cosmic:

https://www.cnbc.com/2020/10/15/oxford-scientists-develop-5-minute-covid-19-antigen-test.html

Today: https://www.cnbc.com/2020/10/15/oxford-scientists-develop-5-minute-covid-19-antigen-test.html

Tomorrow: Paraytec develop 90 second test, with light sensing technology detecting level of infection...

Both important news today and tomorrow

I think if CAPTURE and the light detection system is implemented in conjunction with covid medicines in hospitals it could be a global game changer though. By using such a fast result system with detailed info on protein spikes , doctors will be able to constantly monitor th exact state of infection and therefore able to determine which medicines are effective or not on a patient. This therefore saves vasts amounts of money on unnecessary medicine ****tails being pumped into a patient.. Remsedivir costs $10,000 per treatment after all.

It's very clever and hope the stock market sees what paraytec are onto this Friday.

sng closed at 36p night before sng001 news if I recall funilly enough...
Even more funny, Professor Smythe hasnt tweeted for almost a day, which must be some kind of record.....

I think the real USP of this is that Paraytec's secondary light detection test is able to detect the stage of COVID infection. iabra might be able to do this but as far as I am aware no other company can do (including PCR). Just think, when used in a hospital environment in conjunction with medicine this is an important analytic tool as well but I think everyone including the market has missed this so far..... ;-)

not painful for me :) . near at my buy targets ;-p

For SNG, the majority of people already knew the results were going to be positive before the SNG001 announcement ,but I think most were shocked with the 600% rise. Although you can't compare the two in terms of what they specialize in, they do have a similar share price and market capital characteristics.

There are many questions that need to be answered on Friday for BRH holders and hope we will get them. We can however compare our situation to other "diagnostic"companies:
- Sona Nanotech have a 5-15min test and sensitivity of 84.6% and a specificity of 90.0% . Market cap $500m. $50 a test.
- Avacta POC "pregnancy" 10 min tests charged at £25 set to be launched in 2021. .M cap £ 400m
- Deepverge breathalyzer £4 a chip (per test), plus £20 for breathalyzer , plus £x for replacement mist cannister . And "DVD "reading machine £xxxx initially. Combined market capital £60m
- TT electronics have a partnership with iAbra. No biochemistry/cell biology involved , only microscopic and AI work. Suggested added value to company was £220m on COVID news but many have criticized accuracy/sensitivity. Cost of microscopic and AI machine £20,000. Cost per test £10.
- Paraytec. Clever two stage test utilizing self developed aptamer with secondary thorough test utilizing miniaturized light detection technology. Cost /sensitivity unknown. Market cap £13m.

Whatever happens on Friday ,with Paraytec at least they own their own IP unlike Deepverge or even TTG. Should be an interesting ride on Friday negative or positive ;-)

Jodrell, nobody knows. but I like a good deal whether it be buying or selling. BRH bad news/ or news below expectations = 20-25p. Good news Probably 150p- 250p.

Put in some buy orders at 35 to 36p. Was waiting patiently for a day like this. Hopefully orders get fulfilled before Friday touchwood.

Off subject, Sona Nanotech have a 5-15min test and sensitivity of 84.6% and a specificity of 90.0% . Market cap $500m.

*see companies

Shear, what's the difference btw a 10 and 20 bag or 50 bag. It all becomes irrelevant once you reach a certain standard of wealth and see it companies multibag time after time on stock exchanges I suppose . hehe ;-). Great that this board has a great sense of humour ;-)

I also disagree with your 10 bag statement. That is fictitious.

I think this will 20 bag.

I know everything about NCYT thanks and I'm not disagreeing with you Shear but I gather you are a NCYT holder as well. My decision to sell was very carefully thought out over the weekend (see yesterday's posts) I could easily buy back in at NCYT at a lower price as price has sunk but I 'm just playing a waiting game to accumulate here now.

But I think you will realize Paraytec and Avacta's tests will eventually near 99% accuracy. No test is 100% not even Novacyts .

I am forward thinking about the future . In this situation, it is not dissimilar to a situation to Nokia in 2000, fast forward a few years later where Apple eventually dominated later with a simpler clearer faster phone and dominated the market to the masses.